Sickle cell kidney research study
Part of Blood & lymphatic, Genetic & congenital, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study collects kidney tissue samples from people with sickle cell disease and healthy volunteers to better understand how sickle cell affects the kidneys. If you have sickle cell disease or a related blood disorder, you may help researchers find new ways to protect kidney function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older but not yet 66.
- Your kidney function is at least 15 mL/min (not on dialysis).
- You have sickle cell disease or another hemoglobin disorder (or are a healthy volunteer matched to a participant).
- You are not currently pregnant (can join 4 weeks after giving birth).
- You have not had a sickle cell pain crisis requiring a hospital or ER visit in the last 2 weeks.
- You do not have an active cancer that requires strong chemotherapy (maintenance treatment in remission is okay).
- You are not in prison.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood samples to learn more about sickle cell-related genetics and biology. You might benefit indirectly by helping researchers understand the condition, even though this is laboratory research rather than a medication trial.
This study looks at how different types of sickle cell disease (SS, S/beta0, S/C) are linked to blood clotting and disease severity. It may help doctors better understand the condition and how to treat it.
This study looks at a certain type of blood cell (megakaryocytes) in people with sickle cell disease. It aims to learn more about the disease and is only for patients followed at the Guadeloupe sickle cell center who are in a stable phase (no recent crisis or transfusion).
This study is for adults who have or might have sickle cell trait (carrying the sickle cell gene but not the disease). It aims to understand the health effects of sickle cell trait over time by following participants and collecting health information.
This trial looks at the cells that help make platelets (megakaryocytes) in people with sickle cell disease. By comparing these cells when you are feeling well and during a pain crisis or chest syndrome, researchers hope to learn more about the condition and find better treatments.
This study collects health information and biological samples to better understand kidney disease and support future kidney research. It may help your care indirectly by improving how kidney conditions are recognized and studied.
Hear when a new Sickle Cell Trait trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.